Publications

Kelsh MA. Evaluating biosimilars in observational data: Some methodological considerations. Presented at International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), Dublin, Ireland, August 25–28, 2016.

Katz AJ, Chia VM, Schoonen WM, Kelsh MA. 2015. Acute lymphoblastic leukemia: An assessment of international incidence, survival, and disease burden. Cancer Causes Control 26(11):1627–1642.

Kelsh MA, Chia VM. Historical comparator studies: Strengths, limitations, and analytical considerations in using historical pooled clinical data for evaluating efficacy and safety of new therapies. Presented at International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE) Boston, MA, August 25, 2015.

Erichsen R, Kelsh MA, Oliner KS, Nielsen KB, Frøslev T, Lænkholm AV, et al. Prognostic impact of tumor MET expression among patients with stage IV gastric cancer: A Danish cohort study. Presented at International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), Taipei, Taiwan, October 28–30, 2014.

Chia VM, O’Malley CD, Danese MD, Lindquist KJ, Gleeson ML, Kelsh MA, et al. 2013. Prevalence and incidence of comorbidities in elderly women with ovarian cancer. Gynecol Oncol 129(2):346–352; doi: 10.1016/j.ygyno.2013.02.014. PMID: 23422502.

Kuehn S, Kelsh MA, Kuster N, Sheppard AR, Shum M. 2013. Analysis of mobile phone design features affecting radiofrequency power absorbed in a human head phantom. Bioelectromagnetics 34(6):479–488.

Lowe KA, Chia VM, Taylor A, O’Malley C, Kelsh M, Mohamed M, et al. 2013. An international assessment of ovarian cancer incidence and mortality. Gynecol Oncol 130(1):107–114; doi: 10.1016/j.ygyno.2013.03.026. PMID: 23558050.

Chia VM, O’Malley CD, Danese M, Lindquist K, Gleesen M, Kelsh MA, et al. Comorbid conditions in elderly women with and without ovarian cancer. Presented at International Gynecological Cancer Society Annual Meetings, Vancouver, Canada, October 13–16, 2012.

Chia VM, Lowe KA, O’Malley CD, Kelsh MA, Taylor A, Mowat F, et al. An updated assessment of global ovarian cancer trends. Presented at International Gynecological Cancer Society Annual Meetings, Vancouver, Canada, October 13–16, 2012.

Kanas GP, Taylor A, Primrose JN, Langeberg WJ, Kelsh MA, Mowat FS, et al. 2012. Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors. Clin Epidemiol 4(1):283–301.

Mitchell M, Taylor A, Lowe K, Langeberg W, Alexander D, Kelsh M, et al. Breast cancer bone metastasis prevalence and survival outcomes: A quantitative review of the literature. Presented at the 34th Annual San Antonio Breast Cancer Symposium, San Antonio, TX, December 6–10, 2011.

Shum M, Kelsh MA, Sheppard AR, Zhao K. 2011. An evaluation of self-reported mobile phone use compared to billing records among a group of engineers and scientists. Bioelectromagnetics 32(1):37–48.

Lau EC, Mowat FS, Kelsh MA, Legg JC, Engel-Nitz NM, Watson HN, et al. 2011. Use of electronic medical records (EMR) for oncology outcomes research: Assessing the comparability of EMR information to patient registry and health claims data. Clin Epidemiol 3:259–272.

Mitchell M, Taylor A, Lowe K, Langeberg W, Alexander D, Kelsh M, et al. Prevalence of bone metastasis after breast, lung, and prostate cancers: A systematic and quantitative review of the literature. Presented at the 27th Annual Meetings of International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Chicago, IL, August 14–17, 2011.

Lau EC, Steffey D, Legg JC, Watson HN, Mowat FS, Kelsh MA. The problem of missing data: Using imputation methods to facilitate oncology outcomes research. Presented at the 27th Annual Meetings of International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Chicago, IL, August 14–17, 2011.

Mowat FS, Lau EC, Kelsh MA, Legg JC, Engel-Nitz NM, Watson HN, Collins HL, et al. Assessing the comparability of EMR information to patient registry and health claims data. Presented at the 27th Annual Meetings of International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Chicago, IL, August 14–17, 2011.

Kelsh MA, Shum MS, Sheppard AR, McNeeley M, Kuster N, Lau E, et al. 2011. Measured radiofrequency exposure in various mobile phone-use scenarios. J Expo Sci Environ Epidemiol 21(4):343–354; doi: 10.1038/jes.2010.12. PMID: 20551994.

Taylor A, Kanas G, Primrose JN, Langeberg WJ, Alexander DD, Kelsh MA, et al. Survival after surgical resection of hepatic metastases from colorectal cancer: An updated review and meta-analysis. Presented at 13th World Congress on Gastrointestinal Cancer, Barcelona Spain, June 22–25, 2011.

Kelsh MA, Kucera G, Erdreich L. Meta-analysis of acoustic neuroma and mobile phone use. Presented at BEMS 33rd Annual Meetings, Halifax, Canada, June 12–17, 2011.

Yong M, Kuehn C, Kelsh M, Mitchell M, et al. Associations between platelet count and survival and disease progression in thrombocytopenic patients with myelodysplastic syndromes. Presented at the American Society of Hematology, Orlando, FL, December 2010.